Skip to Main Content

Paper Details

SGLT2 inhibitor, canagliflozin, ameliorates cardiac inflammation in experimental autoimmune myocarditis.
Int Immunopharmacol
17
2022
Author NameAffiliation
Qi LongUnion Hospital, Tongji Medical College, Huazhong University of Science and Technology
  • 1 - 1

Datasets

Release 1.2